TaylorMade deal attracts positive response from investors Centroid Investment Partners to close deal next month
Translated by Kim So-in 공개 2021-06-29 08:42:08
이 기사는 2021년 06월 29일 07시50분 thebell에 표출된 기사입니다
Centroid Investment Partners has finalized a deal structure of its acquisition of golf equipment company TaylorMade, with the firm planning to close the deal next month.An amount of acquisition financing for the takeover of TaylorMade has significantly been increased from $700 million to $950 million, thanks to positive response from investors, industry sources said Friday. The increased amount will be used to repay TaylorMade’s debts worth $2.5 trillion.
The acquisition financing has been jointly arranged by Shinyoung Securities, KB Kookmin Bank, and Hana Financial Investment. It is known that they first proposed repaying TaylorMade's existing debt, with the acquisition finance quickly overbooked. The arrangers seem to have focused on the fact that the current lenders may enhance investment stability by securing enough collateral if existing borrowings are paid.
The acquisition financing will be comprised of two tranches, including a $725 million senior debt with a yield to maturity of 4.7% and a $225 million subordinated debt with a yield to maturity of 7.5%.
Mezzanine loan and equity are structured to consist of convertible preference shares (CPS) worth about $430 million and equity of $510 million, respectively.
TaylorMade recorded earnings before interest, taxes, depreciation, and amortization (EBITDA) of 135 billion won in the first quarter of this year, slightly exceeding the last year’s EBITDA of 127.5 billion. Market insiders estimate this year’s EBITDA to be between 170 billion won and 200 billion won.
The Korean Federation of Community Credit Cooperatives will invest 200 billion won in equity investments and 100 billion won in CPS as an anchor investor. Strategic investor The Nature Holdings will invest 100 billion won in equity investments.
Centroid Investment Partners plans to close the deal next month and start a post-merger integration process. (Reporting by Se-hun Jo)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- [i-point]'자가면역질환 신약' 이노보테라퓨틱스, 미국 임상 1상 '성공적'
- [i-point]폴라리스오피스, 엔비디아 ‘커넥트’ 공식 파트너 선정
- [i-point]신성이엔지, 한국종합기술·다스코와 연료전지 발전사업 협약
- [i-point]신테카바이오, 'PEGS 보스턴 2025' 참가
- [AACR 2025]첫 구두발표 진씨커, 경쟁사 넘보는 '유전자가위 액체생검'
- [AACR 2025]이뮨온시아 'CD47' 안전성 굳히기 "경쟁약과 다르다"
- [AACR 2025]항암 신약 항체 대신 '페라틴', 셀레메디 플랫폼 데뷔전
- [AACR 2025]근거 쌓는 '루닛 스코프' 빅파마 공동연구 쇼케이스
- [변곡점 선 콜마비앤에이치]변화의 마지막 카드, 경영진 교체 '강수' 두나
- [변곡점 선 콜마비앤에이치]속절없는 주가 하락 '트리거', 주가 부양 의지 없었나